KETOROLAC TROMETHAMINE INJECTION

The Defense Logistics Agency awarded a single-line-item delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC CAGE 1UNB0 for one package of KETOROLAC TROMETHAMINE INJECTION identified by NSN 6505017234825 at a total price of $83.39, with delivery scheduled for August 4, 2026, FOB destination at Fort Hood Texas. The contract is structured under FAR Part 12 as a commercial item acquisition with a firm-fixed-price structure, and the contractor is responsible for traceable shipment via non-parcel post methods, with each container required to display the Traceable Control Number TCN and appropriate NSN and manufacturer CAGE codes 72QE3 or 57KZ6. Although no explicit MIL-STD packaging preservation or marking standards are cited, compliance with DLA logistics protocols is implied through the use of government logistics identifiers. The contract includes the FAR clause 52.222-50 on Combating Trafficking in Persons, and while the awardee’s CAGE code is confirmed, no socioeconomic certifications or unique entity identifier are explicitly documented. The government retains inspection and acceptance authority at the delivery point, and invoicing procedures are referenced to an unprovided addendum. Payment details and contracting officer information are not specified in the available data, and while a single attachment titled PPVG GEN V SPE2DX-25-D-9900 NEW SECONDARY DVD BASE ADMIN.pdf is noted, its content remains inaccessible. There are no option periods, quantity ranges, or special contractual requirements such as security clearances or OCI provisions identified in the disclosed documents.